NCIt definition : A humanized monoclonal antibody directed against the pancreatic cancer antigen MUC1,
with potential antineoplastic activity. Clivatuzumab binds to tumor cells expressing
the MUC1 antigen and prevents MUC1-mediated signaling. MUC1, a mucin antigen, is overexpressed
in pancreatic cancer but not in normal, healthy pancreatic cells.;